Verrica Pharmaceuticals Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 Financial Results, Announced Senior Leadership Changes, and Is Exploring Strategies to Strengthen Its Balance Sheet. Additionally, RBC Capital...

Benzinga · 04:34

Verrica Pharmaceuticals Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 Financial Results, Announced Senior Leadership Changes, and Is Exploring Strategies to Strengthen Its Balance Sheet. Additionally, RBC Capital Downgraded the Stock From Outperform to Sector Perform and Cut Its Price Target From $11 to $2.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

Verrica Pharmaceuticals Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 Financial Results, Announced Senior Leadership Changes, and Is Exploring Strategies to Strengthen Its Balance Sheet. Additionally, RBC Capital...

Risk Disclaimer